当前位置:首页 - 行情中心 - 三元生物(301206) - 财务分析 - 现金流量表

三元生物

(301206)

  

流通市值:30.81亿  总市值:47.85亿
流通股本:1.30亿   总股本:2.02亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金437,550,314.23214,238,273.18711,077,821.77544,775,312.94
  收到的税费返还29,999,486.7313,645,722.849,037,630.4934,528,768.8
  收到其他与经营活动有关的现金4,952,131.493,009,395.357,558,470.6111,245,269.71
  经营活动现金流入小计472,501,932.45230,893,391.33767,673,922.87590,549,351.45
  购买商品、接受劳务支付的现金338,609,010.46134,746,443.14646,245,659.32468,868,978.81
  支付给职工以及为职工支付的现金32,337,949.0216,779,668.8155,513,324.9641,365,165.5
  支付的各项税费13,356,855.422,789,017.1729,415,770.5243,395,785.09
  支付其他与经营活动有关的现金14,560,888.2514,256,813.9413,683,431.0511,816,941.42
  经营活动现金流出小计398,864,703.15168,571,943.06744,858,185.85565,446,870.82
  经营活动产生的现金流量净额73,637,229.362,321,448.2722,815,737.0225,102,480.63
二、投资活动产生的现金流量:
  收回投资收到的现金4,981,000,0003,040,000,0008,896,799,0008,363,400,000
  取得投资收益收到的现金42,211,062.1636,297,674.86294,941,867.34293,654,242.99
  处置固定资产、无形资产和其他长期资产收回的现金净额--99,83563,635
  收到的其他与投资活动有关的现金60,000-9,440,0009,440,000
  投资活动现金流入小计5,023,271,062.163,076,297,674.869,201,280,702.348,666,557,877.99
  购建固定资产、无形资产和其他长期资产支付的现金61,009,41339,674,025.22199,145,003.39139,696,433.7
  投资支付的现金4,674,026,408.233,165,026,408.238,457,799,0008,152,400,000
  支付其他与投资活动有关的现金60,000-9,490,0009,150,000
  投资活动现金流出小计4,735,095,821.233,204,700,433.458,666,434,003.398,301,246,433.7
  投资活动产生的现金流量净额288,175,240.93-128,402,758.59534,846,698.95365,311,444.29
三、筹资活动产生的现金流量:
  吸收投资收到的现金--400,000-
  收到其他与筹资活动有关的现金--3,000,0002,000,000
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--3,400,0002,000,000
  分配股利、利润或偿付利息支付的现金--348,646,923.76239,296,365.31
  支付其他与筹资活动有关的现金--46,485,550.5645,491,454.4
  筹资活动现金流出平衡项目--00
  筹资活动现金流出小计--395,132,474.32284,787,819.71
  筹资活动产生的现金流量净额平衡项目--00
  筹资活动产生的现金流量净额---391,732,474.32-282,787,819.71
四、汇率变动对现金及现金等价物的影响-1,371,869.18-1,258,762.9-1,286,823.88-754,789.21
五、现金及现金等价物净增加额360,440,601.05-67,340,073.22164,643,137.77106,871,316
  加:期初现金及现金等价物余额324,935,490.8324,935,490.8160,292,353.03160,292,353.03
  期末现金及现金等价物余额685,376,091.85257,595,417.58324,935,490.8267,163,669.03
补充资料:
  净利润50,397,586.8-91,296,559.96-
  资产减值准备2,133,048.7-272,312.9-
  固定资产和投资性房地产折旧40,363,687.87-72,193,447.79-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧40,363,687.87-72,193,447.79-
  无形资产摊销2,044,291.26-1,341,332.52-
  处置固定资产、无形资产和其他长期资产的损失---65,753.16-
  公允价值变动损失-1,717,740.7--367,116.65-
  投资损失-23,143,436.07--69,511,758.02-
  递延所得税-5,219,756.79--7,575,744.44-
    递延所得税负债增加-5,219,756.79--7,575,744.44-
  存货的减少-29,279,164.84--32,146,961.88-
  经营性应收项目的减少14,154,087.39-40,432,240.35-
  经营性应付项目的增加24,194,763.67--72,883,974.2-
  现金的期末余额685,376,091.85-324,935,490.8-
  减:现金的期初余额324,935,490.8-160,292,353.03-
  现金及现金等价物的净增加额360,440,601.05-164,643,137.77-
公告日期2026-08-282026-04-292026-04-292025-10-27
审计意见(境内)标准无保留意见
TOP↑